Published in J Diabetes Res on June 17, 2013
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med (2007) 8.31
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med (2009) 7.08
Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ (2010) 6.05
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med (2006) 5.51
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia (2012) 4.82
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Comparison of treatment of renal calculi by open surgery, percutaneous nephrolithotomy, and extracorporeal shockwave lithotripsy. Br Med J (Clin Res Ed) (1986) 3.99
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 3.57
Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol (1980) 3.21
Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int (2007) 3.17
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care (2013) 2.96
Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem (2000) 2.79
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia (2007) 2.51
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2003) 2.28
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care (2014) 2.21
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia (2013) 2.19
Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One (2012) 2.19
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12
Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review. Diabet Med (2000) 2.10
Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis. Ann Intern Med (2015) 2.09
The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med (2010) 2.09
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia (2011) 2.06
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis (2009) 2.03
Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res (2013) 2.01
Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia (2009) 1.99
[Chronic renal disease as cardiovascular risk factor]. Ned Tijdschr Geneeskd (2008) 1.94
Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia (2006) 1.90
External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med (2013) 1.90
Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab (2001) 1.89
Features of primary health care teams associated with successful quality improvement of diabetes care: a qualitative study. Fam Pract (2001) 1.84
Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer (2001) 1.80
Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract (2009) 1.79
Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol (1980) 1.70
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess (2012) 1.70
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia (2008) 1.70
Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria. Br J Gen Pract (2013) 1.69
Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord (2001) 1.68
The steinstrasse: A legacy of extracorporeal lithotripsy? 1988. Eur Urol (2006) 1.67
Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci U S A (1976) 1.67
Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain. Br Med J (Clin Res Ed) (1985) 1.66
Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf) (2013) 1.66
The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract (2010) 1.65
The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? Diabet Med (2011) 1.61
In-training assessment: qualitative study of effects on supervision and feedback in an undergraduate clinical rotation. Med Educ (2006) 1.56
Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med (2013) 1.51
Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens (2004) 1.51
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis (2008) 1.50
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50
Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabet Med (2014) 1.49
Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes. Lancet (1999) 1.48
Purification and characterization of a monoclonal T-cell suppressor factor specific for poly(LGlu60LAla30LTyr10). Proc Natl Acad Sci U S A (1982) 1.46
Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia (2005) 1.46
Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med (2007) 1.45
Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond) (2000) 1.44
Solution structure of an A-tract DNA bend. J Mol Biol (2001) 1.43
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci (Lond) (2003) 1.43
Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia. Neth J Med (2010) 1.42
Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia (2011) 1.42
Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND): process modelling of pilot study. Patient Educ Couns (2006) 1.41
Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabet Med (2013) 1.41
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2005) 1.40
The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J Immunol (1976) 1.40
Retropubic extraperitoneal endoscopy. Med J Aust (1993) 1.40
Attitudes to lifestyle risk factors for coronary heart disease amongst South Asians in Leicester: a focus group study. Fam Pract (2000) 1.39
Self-monitoring of blood glucose versus self-monitoring of urine glucose in adults with newly diagnosed Type 2 diabetes receiving structured education: a cluster randomized controlled trial. Diabet Med (2014) 1.39
A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabet Med (2010) 1.38
Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nat Rev Endocrinol (2012) 1.38
Discontinuation of metformin in type 2 diabetes patients treated with insulin. Neth J Med (2002) 1.38
A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabet Med (2006) 1.36
Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol (1976) 1.36
Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia (2013) 1.36
Effectiveness of clinical rotations as a learning environment for achieving competences. Med Teach (2004) 1.35
Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis (1973) 1.35
Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. Cell Immunol (1978) 1.31
Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2008) 1.29
Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest (2003) 1.28
Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax (2008) 1.26
Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? Diabetologia (2013) 1.26
Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabet Med (2012) 1.24
Self-reported sitting time and markers of inflammation, insulin resistance, and adiposity. Am J Prev Med (2012) 1.23